
ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
| Revenue (TTM) | $3.37B |
| Gross Profit (TTM) | $1.38B |
| EBITDA | $534.85M |
| Operating Margin | 10.10% |
| Return on Equity | -41.40% |
| Return on Assets | 3.57% |
| Revenue/Share (TTM) | $37.19 |
| Book Value | $21.78 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | 0.83 |
| EV/Revenue | 1.563 |
| EV/EBITDA | 9.63 |
| Quarterly Earnings Growth (YoY) | -63.60% |
| Quarterly Revenue Growth (YoY) | -0.40% |
| Shares Outstanding | $93.10M |
| Float | $86.77M |
| % Insiders | 1.52% |
| % Institutions | 147.21% |
Volatility is currently contracting

ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC). On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney's Office for the Southern District of New York as well as a grand jury subpoena from the United States District Cour.

SAN DIEGO, July 31, 2026 /PRNewswire/ -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.

Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.

ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.

SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.

SAN DIEGO--(BUSINESS WIRE)---- $ACHC #Medicine--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed.The case is continuing after the Court denied defendants' motion to dismiss the amended complaint. The ruling means the case can proceed past the motion-to-dismiss stage. It does not determine whether the allegations are true or establish liability. Investors who purchased or otherwise acquired Acadia Healt.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Wednesday, July 29, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be availabl.

The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACHC and any ticker you trade — then tracks every position and per-strategy win rate.